Skip to main content

Advertisement

Table 1 Patient demographics summarized for the overall population and by biopsy diagnosis

From: An expanded biomarker panel for the detection of prostate cancer from urine DNA

Variable Cases (n = 42) Controls (n = 52)
Age
 n (%) 42 (100.0%) 50 (96.2%)
 Median 66 64
 Mean (SD) 67.1 (7.1) 63.9 (7.6)
 Range 48–84 50–83
PSA
 n (%) 40 (95%) 51 (98.1%)
 Median 6.4 5.2
 Mean (SD) 7.1 (3.3) 5.6 (2.7)
 Range 3.26–18.92 0.63–14.9
Race
 Alaskan Native 1 (2.4%) 0 (0.0%)
 Asian 0 (0.0%) 1 (1.9%)
 Black 4 (9.5%) 5 (9.6%)
 Hispanic 1 (2.4%) 1 (1.9%)
 White 36 (85.7%) 44 (84.6%)
 Missing 0 (0.0%) 1 (1.9%)
Urine samples
 DRE and FV 28 (66.7%) 32 (61.5%)
 DRE only 10 (23.8%) 17 (32.7%)
 FV only 4 (9.5%) 3 (5.8%)
Gleason score
 n 39 (92.9%) NA
 Mean (SD) 7.1 (1.3)  
 ≤ 7 26 (61.9%)  
 > 7 13 (30.9%)  
 Missing 3 (7.1%)  
Positive cores
 n 39 (92.9%) NA
 Mean (SD) 4.2 (3.6)  
 ≤ 3 19 (45.2%)  
 > 3 20 (47.6%)  
 Missing 3 (7.1%)  
  1. The mean PSA for cases was calculated after excluding 2 outliers which were greater than 2X the highest remaining PSA value from cases. NA: not applicable